Hantavirus Outbreak on MV Hondius Sparks Expert Analysis
Following a recent outbreak of the deadly hantavirus aboard the cruise ship MV Hondius, Dr. Céline Gounder, editor-at-large at KFF Health News and infectious disease specialist, engaged with multiple media outlets to address public concerns about the disease.
WHO: Public Risk from Hantavirus Is ‘Absolutely Low’
On May 8, Gounder appeared on MS Now to clarify who faces risk of infection and how hantavirus spreads. She also addressed whether travelers should be concerned about the outbreak.
Key Differences Between Hantavirus and COVID-19
On the same day, Gounder joined CBS News’ The Takeout to explain the distinctions between hantavirus and COVID-19, emphasizing what the public should realistically prioritize in terms of health concerns.
Essential Hantavirus Facts and Government Response
On May 9, Gounder appeared on CBS Saturday Morning to outline critical information about hantavirus, including the measures the U.S. government is implementing to contain the outbreak.
About KFF Health News
KFF Health News is a national newsroom dedicated to producing in-depth journalism on health issues. It operates as one of the core programs under KFF, an independent organization specializing in health policy research, polling, and journalism.
Source and Reuse Information
This article first appeared on KFF Health News and is republished under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Related articles
PSA Screening Significantly Lowers Prostate Cancer Death Risk, Cochrane Review Confirms
Prostate-specific antigen (PSA) blood testing is likely to reduce the risk of death from prostate cancer, found a new review published on Thursday by...
Ballmaxxing: The Dangerous Testicle Enhancement Trend You Need to Know About
Experts say that “Ballmaxxing” may lead to permanent damage. Image Credit: Heathline/Paloma Rincon Studio/GettyImages Ballmaxxing is the latest social...
STAT Unveils 'The Deadliest Drug' Investigation: Alcohol-Related Deaths Surpass 178,000 Annually in the U.S.
Dear Readers, I want to bring your attention to “The Deadliest Drug,” a new STAT investigative series about our nation’s failure to address excessive...
CDC to Relocate 160+ Monkeys to Sanctuary in Bid to End Animal Testing
As part of efforts to phase out the use of monkeys in research, the Centers for Disease Control and Prevention intends to transfer more than 160 macaq...
Who Will Lead the FDA Next? The Search for a New Commissioner Heats Up
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to...
Study Links High Air Pollution to Increased Post-Surgical Complications on Utah’s Wasatch Front
New research on Utah’s Wasatch Front—which occasionally experiences the worst air quality in the nation—has found an association between high air poll...
BeOne Secures FDA Approval for Novel Lymphoma Cell Therapy, Advancing Autoimmune Treatment Pipeline
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Biotech’s cell therapy boo...
Biogen’s Tau-Targeting Alzheimer’s Drug Shows Promise in Phase 2 Trial; Takeda to Cut 4,500 Jobs by 2026
Rise and shine, everyone, another busy day is on the way. And it is getting off to a pleasant start here on the Pharmalot campus, where clear blue ski...